TVGN — Tevogen Bio Holdings Inc.

Opening the full analysis uses 1 of your 3 free tickers today.

Open full analysis

Chart, dilution, float and news for TVGN in the TickerWise workspace.

Tevogen Bio Holdings Inc. operates as a clinical-stage biotechnology company that develops off-the-shelf precision T cell therapeutics in virology, oncology, and neurology. Its lead investigational precision T cell product, TVGN 489, is designed to address the unmet need of acute-risk COVID-19 patients, as well as a subset of patients suffering from long COVID. The company is based in Warren, New Jersey.

Company profile

• Sector: Healthcare
• Industry: Biotechnology
• Country: US
• Exchange: NASDAQ
• Employees: 18
• Website: https://tevogen.com

Latest SEC filings for TVGN

• 2026-05-1510-Q
• 2026-04-3010-K/A
• 2026-04-228-K
• 2026-03-3110-K
• 2026-03-258-K
• 2026-03-25424B3
• 2026-03-048-K
• 2026-03-04424B3
• 2026-02-26424B3

Opening the full analysis uses 1 of your 3 free tickers today.

Open full analysis

Educational tool only — not investment advice.